الانتقال إلى المحتوى الرئيسي

اكتب مراجعة على PREreview

Pre-existing antibodies and age shape the immune response following EV-A71 vaccine: a prospective serological study among the Chinese pediatric population

نُشر
الخادم
medRxiv
DOI
10.1101/2025.09.17.25335968

Hand, foot, and mouth disease (HFMD), primarily caused by enterovirus A71 (EV-A71), poses significant pediatric health risks in the Asia-Pacific region, with vaccination being critical for prevention. Using longitudinal serological data from 1 585 Chinese children in a 2019–2020 prospective study (combining clinical trial and cohort samples), the present study assessed how pre-vaccination antibody titers and age influence EV-A71 vaccine response. EV-A71-specific antibodies were measured via a modified cytopathogenic effect assay, with geometric mean titers (GMTs) and fold increases (GMFIs) analyzed. At baseline, 3.9% (N = 61) of children were seropositive. After vaccination, those with high pre-existing titers exhibited higher GMTs, compared to those with low-level or undetectable titers (GMTs: 10.30 [95% CI: 9.09, 11.52] vs . 7.58 [95% CI: 6.86, 8.29] vs . 6.92 [95% CI: 6.82, 7.02]; GMFIs: 3.36 [95% CI: 1.97, 4.75] vs . 4.23 [95% CI: 3.48, 4.98] vs . 4.92 [95% CI: 4.82, 5.02]).

Generalized additive models revealed that predicted GMTs peaked (8.78) at a baseline titer of 10.20, while GMFIs declined with higher pre-vaccination titers. Vaccine-induced responses also varied with age, showing periodic increases in children under 36 months. Collectively, these findings quantify the effects of pre-existing antibodies and age on the antibody level following vaccination, highlighting the importance of tailoring immunization schedules based on both pre-existing immunity and age. Accordingly, immune-naïve children should be vaccinated as early as possible.

يمكنك كتابة مراجعة PREreview لـ Pre-existing antibodies and age shape the immune response following EV-A71 vaccine: a prospective serological study among the Chinese pediatric population. مراجعة PREreview هي مراجعة لمسودة بحثية أولية، ويمكن أن تتراوح بين بضع جمل وتقرير مطوّل، على غرار تقرير مراجعة الأقران الذي تنظمه المجلات العلمية.

قبل أن تبدأ

سنطلب منك تسجيل الدخول باستخدام معرّف ORCID الخاص بك. إذا لم يكن لديك معرّف، يمكنك إنشاء واحد.

ما هو معرّف ORCID؟

يُعدّ معرّف ORCID معرّفًا فريدًا يميّزك عن كل من يحمل اسمًا مطابقًا أو مشابهًا لاسمك.

ابدأ الآن